Correlation Between Phathom Pharmaceuticals and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and Structure Therapeutics American, you can compare the effects of market volatilities on Phathom Pharmaceuticals and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and Structure Therapeutics.
Diversification Opportunities for Phathom Pharmaceuticals and Structure Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Phathom and Structure is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Phathom Pharmaceuticals and Structure Therapeutics
Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to generate 3.38 times less return on investment than Structure Therapeutics. But when comparing it to its historical volatility, Phathom Pharmaceuticals is 1.23 times less risky than Structure Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,500 in Structure Therapeutics American on September 6, 2024 and sell it today you would earn a total of 1,855 from holding Structure Therapeutics American or generate 123.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 93.74% |
Values | Daily Returns |
Phathom Pharmaceuticals vs. Structure Therapeutics America
Performance |
Timeline |
Phathom Pharmaceuticals |
Structure Therapeutics |
Phathom Pharmaceuticals and Structure Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Phathom Pharmaceuticals and Structure Therapeutics
The main advantage of trading using opposite Phathom Pharmaceuticals and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.The idea behind Phathom Pharmaceuticals and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |